vs
Side-by-side financial comparison of AvalonBay Communities (AVB) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $767.9M, roughly 1.4× AvalonBay Communities). AvalonBay Communities runs the higher net margin — 9040.6% vs -127.8%, a 9168.4% gap on every dollar of revenue. On growth, AvalonBay Communities posted the faster year-over-year revenue change (3.7% vs -2.5%). AvalonBay Communities produced more free cash flow last quarter ($1.4B vs $148.6M). Over the past eight quarters, AvalonBay Communities's revenue compounded faster (3.8% CAGR vs 1.3%).
AvalonBay Communities, Inc. is a publicly traded real estate investment trust that invests in apartments.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
AVB vs PRGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $767.9M | $1.1B |
| Net Profit | $166.0M | $-1.4B |
| Gross Margin | — | 32.6% |
| Operating Margin | 64.2% | -116.0% |
| Net Margin | 9040.6% | -127.8% |
| Revenue YoY | 3.7% | -2.5% |
| Net Profit YoY | -41.2% | -3093.9% |
| EPS (diluted) | $1.18 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $767.9M | $1.1B | ||
| Q3 25 | $766.8M | $1.0B | ||
| Q2 25 | $760.2M | $1.1B | ||
| Q1 25 | $745.9M | $1.0B | ||
| Q4 24 | $740.5M | $1.1B | ||
| Q3 24 | $734.3M | $1.1B | ||
| Q2 24 | $726.0M | $1.1B | ||
| Q1 24 | $712.9M | $1.1B |
| Q4 25 | $166.0M | $-1.4B | ||
| Q3 25 | $381.3M | $7.5M | ||
| Q2 25 | $268.7M | $-8.4M | ||
| Q1 25 | $236.6M | $-6.4M | ||
| Q4 24 | $282.1M | $-44.4M | ||
| Q3 24 | $372.5M | $-21.0M | ||
| Q2 24 | $253.9M | $-108.4M | ||
| Q1 24 | $173.4M | $2.0M |
| Q4 25 | — | 32.6% | ||
| Q3 25 | — | 36.1% | ||
| Q2 25 | — | 34.4% | ||
| Q1 25 | — | 37.6% | ||
| Q4 24 | — | 33.9% | ||
| Q3 24 | — | 37.2% | ||
| Q2 24 | — | 37.0% | ||
| Q1 24 | — | 33.1% |
| Q4 25 | 64.2% | -116.0% | ||
| Q3 25 | 65.7% | 7.0% | ||
| Q2 25 | 67.6% | 4.3% | ||
| Q1 25 | 68.5% | 4.5% | ||
| Q4 24 | 63.1% | 10.0% | ||
| Q3 24 | 65.4% | 7.4% | ||
| Q2 24 | 66.6% | -2.5% | ||
| Q1 24 | 67.2% | -5.1% |
| Q4 25 | 9040.6% | -127.8% | ||
| Q3 25 | 49.7% | 0.7% | ||
| Q2 25 | 35.3% | -0.8% | ||
| Q1 25 | 31.7% | -0.6% | ||
| Q4 24 | 38.1% | -3.9% | ||
| Q3 24 | 50.7% | -1.9% | ||
| Q2 24 | 35.0% | -10.2% | ||
| Q1 24 | 24.3% | 0.2% |
| Q4 25 | $1.18 | $-10.23 | ||
| Q3 25 | $2.68 | $0.05 | ||
| Q2 25 | $1.88 | $-0.06 | ||
| Q1 25 | $1.66 | $-0.05 | ||
| Q4 24 | $1.99 | $-0.32 | ||
| Q3 24 | $2.61 | $-0.15 | ||
| Q2 24 | $1.78 | $-0.79 | ||
| Q1 24 | $1.22 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $187.2M | — |
| Total DebtLower is stronger | $9.3B | — |
| Stockholders' EquityBook value | $11.6B | $2.9B |
| Total Assets | $22.2B | $8.5B |
| Debt / EquityLower = less leverage | 0.80× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $187.2M | — | ||
| Q3 25 | $123.3M | $432.1M | ||
| Q2 25 | $102.8M | $454.2M | ||
| Q1 25 | $53.3M | $409.9M | ||
| Q4 24 | $108.6M | $558.8M | ||
| Q3 24 | $552.4M | $1.5B | ||
| Q2 24 | $545.8M | $542.8M | ||
| Q1 24 | $287.9M | $658.5M |
| Q4 25 | $9.3B | — | ||
| Q3 25 | $8.7B | — | ||
| Q2 25 | $8.7B | — | ||
| Q1 25 | $8.3B | — | ||
| Q4 24 | $8.1B | — | ||
| Q3 24 | $8.4B | — | ||
| Q2 24 | $8.4B | — | ||
| Q1 24 | $8.0B | — |
| Q4 25 | $11.6B | $2.9B | ||
| Q3 25 | $11.9B | $4.4B | ||
| Q2 25 | $11.9B | $4.5B | ||
| Q1 25 | $11.9B | $4.4B | ||
| Q4 24 | $11.9B | $4.3B | ||
| Q3 24 | $11.9B | $4.6B | ||
| Q2 24 | $11.7B | $4.5B | ||
| Q1 24 | $11.7B | $4.7B |
| Q4 25 | $22.2B | $8.5B | ||
| Q3 25 | $21.9B | $10.1B | ||
| Q2 25 | $21.8B | $10.1B | ||
| Q1 25 | $21.2B | $9.8B | ||
| Q4 24 | $21.0B | $9.6B | ||
| Q3 24 | $21.3B | $11.2B | ||
| Q2 24 | $21.0B | $10.4B | ||
| Q1 24 | $20.6B | $10.6B |
| Q4 25 | 0.80× | — | ||
| Q3 25 | 0.73× | — | ||
| Q2 25 | 0.72× | — | ||
| Q1 25 | 0.70× | — | ||
| Q4 24 | 0.68× | — | ||
| Q3 24 | 0.70× | — | ||
| Q2 24 | 0.71× | — | ||
| Q1 24 | 0.68× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.7B | $175.4M |
| Free Cash FlowOCF − Capex | $1.4B | $148.6M |
| FCF MarginFCF / Revenue | 183.5% | 13.4% |
| Capex IntensityCapex / Revenue | 34.1% | 2.4% |
| Cash ConversionOCF / Net Profit | 10.07× | — |
| TTM Free Cash FlowTrailing 4 quarters | $2.5B | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7B | $175.4M | ||
| Q3 25 | $477.0M | $51.7M | ||
| Q2 25 | $377.8M | $75.9M | ||
| Q1 25 | $415.9M | $-64.5M | ||
| Q4 24 | $1.6B | $312.6M | ||
| Q3 24 | $486.2M | $42.2M | ||
| Q2 24 | $380.0M | $9.5M | ||
| Q1 24 | $412.9M | $-1.4M |
| Q4 25 | $1.4B | $148.6M | ||
| Q3 25 | $402.2M | $29.8M | ||
| Q2 25 | $317.1M | $56.7M | ||
| Q1 25 | $367.5M | $-90.0M | ||
| Q4 24 | $1.4B | $274.9M | ||
| Q3 24 | $434.2M | $15.1M | ||
| Q2 24 | $333.0M | $-18.9M | ||
| Q1 24 | $375.4M | $-26.5M |
| Q4 25 | 183.5% | 13.4% | ||
| Q3 25 | 52.5% | 2.9% | ||
| Q2 25 | 41.7% | 5.4% | ||
| Q1 25 | 49.3% | -8.6% | ||
| Q4 24 | 191.0% | 24.2% | ||
| Q3 24 | 59.1% | 1.4% | ||
| Q2 24 | 45.9% | -1.8% | ||
| Q1 24 | 52.7% | -2.4% |
| Q4 25 | 34.1% | 2.4% | ||
| Q3 25 | 9.8% | 2.1% | ||
| Q2 25 | 8.0% | 1.8% | ||
| Q1 25 | 6.5% | 2.4% | ||
| Q4 24 | 26.1% | 3.3% | ||
| Q3 24 | 7.1% | 2.5% | ||
| Q2 24 | 6.5% | 2.7% | ||
| Q1 24 | 5.3% | 2.3% |
| Q4 25 | 10.07× | — | ||
| Q3 25 | 1.25× | 6.89× | ||
| Q2 25 | 1.41× | — | ||
| Q1 25 | 1.76× | — | ||
| Q4 24 | 5.70× | — | ||
| Q3 24 | 1.31× | — | ||
| Q2 24 | 1.50× | — | ||
| Q1 24 | 2.38× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVB
Segment breakdown not available.
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
